Mike Chen, president and CEO of ACROBiosystems, shares his global success as a manufacturer of recombinant proteins supporting biologics R&D and…

Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market…

The UAE ranks among the world's fastest for new drug approvals, ranking first for two cancer drugs and second for many others, such as blockbuster…

The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long…

China’s new Amended Drug Administration Law is being enacted to strengthen and streamline its regulation of the pharmaceutical industry as well as…

China's roll-out of a 25-province expansion to the 4+7 pilot procurement scheme has seen pharma companies scrambling to cut prices for their drugs…

Eric Bouteiller outlines the paradigm shift occurring in China around rare diseases and how the country has the potential to lead the global…

Today Su, CEO of Golden Biotechnology, introduces the innovative biotech developing a revolutionary botanical drug derived from the Taiwanese fungus…

Arthur Kadurin, CEO of Insilico Medicine Taiwan, tells us how artificial intelligence can change drug discovery process using the innovative…

Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare disease patient himself, he is…

Long regarded as a neglected backwater within the drug discovery landscape and the preserve of only a handful of niche players, the rare disease space…

The 28th February 2019, marks the twelfth international Rare Disease Day. On and around this day hundreds of patient organisations from countries and…